TrialInternational journal of clinical oncology2019

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Satoshi Hamauchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.